Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-10-020854)

Filing Details

Accession Number:: 0001225208-10-020854
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-09-14 17:54:27
Reporting Period:: 2010-09-10

Filing Date:: 2010-09-14
Accepted Time:: 2010-09-14 17:54:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
14272	Bristol Myers Squibb Co	BMY	Pharmaceutical Preparations (2834)	220790350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341069	C Joseph Caldarella	345 Park Avenue New York NY 10154	Vp & Financial Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	Acquisiton	2010-09-10	24,138	$23.14	55,806	No	4	M	Direct
Common Stock, $0.10 Par Value	Disposition	2010-09-10	24,138	$27.04	31,668	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.10 Par Value	Option (right to buy)	Disposition	2010-09-10	24,138	$27.04	24,138	$23.14

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2004-03-04	2013-03-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	1,424	Indirect	By BMY Savings & Investment Program

Footnotes

Based on a plan statement as of the end of the most recent fiscal quarter.